Policies & Disclaimers  |  Contact Us  |  Site Map  |  Important Safety Information   
Inhaled Ventavis® (iloprost) Inhalation Solution Breathe In Your Second Chance For Patients with Pulmonary Arterial Hypertension with NYHA Class III or IV Symptoms

PAH Learning Center

Please be advised that this information is provided for educational purposes only. It is not intended to take the places of a clinical diagnosis or proper medical advice from a fully qualified health professional.

Actelion Pharmaceuticals encourages patients to seek the services of a qualified doctor for any personal health concerns.

 		09 152 01 00 0909

Read about:

  • What is PAH?
  • Signs and Symptoms
  • Diagnosing PAH
  • Treating PAH
  • Living with PAH
  • Useful Links
    		•


    IMPORTANT SAFETY INFORMATION:
    Because it lowers your blood pressure, Ventavis may cause dizziness, lightheadedness, and fainting. With Ventavis, the most common side effects are reddening of the face caused by dilation of blood vessels (flushing), increased cough, low blood pressure (hypotension), headaches, nausea, spasm of the jaw muscles that causes trouble opening your mouth, and fainting (syncope); other serious adverse events reported with the use of Ventavis include congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Before you start taking Ventavis, talk to your doctor to make sure you understand the side effects you might get.

    I-neb AAD is a registered trademark of Philips Respironics.

    Please see full Prescribing Information

    For more information about
    Ventavis, please call
    1-866-ACTELION (1-866-228-3546).

    Policies & Disclaimers  |  Contact Us   |  Site Map  |  Important Safety Information

    THIS SITE IS INTENDED FOR U.S. AUDIENCES ONLY.
    SECOND WIND is a licensed trademark of Pulmonary Rehabilitation Associates.
    ©2010 Actelion Pharmaceuticals US, Inc. All rights reserved.

    		ACTELION